María Erendira
Calleja Cervantes
Bioinformática
Instituto de Investigación Sanitaria de Navarra
Pamplona, EspañaPublikationen in Zusammenarbeit mit Forschern von Instituto de Investigación Sanitaria de Navarra (1)
2022
-
In vivo CRISPR-Cas9 inhibition of hepatic LDH as treatment of primary hyperoxaluria
Molecular Therapy - Methods and Clinical Development, Vol. 25, pp. 137-146